Belluscura (BELL ) CEO, Robert Rauker, discusses the recent oversubscribed fundraise and the addition to their IP portfolio. Bob talks through the latest version of their Xplorer product and future addtions to the Company's products range.
Belluscura is a medical device company founded in the U.K. with headquarters in the United States. Using patented oxygen enrichment technology, our mission is to help improve the quality of life for millions of people around the world.
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.
